(Q33399986)

English

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

phase I clinical trial

0 references

Apostolia Maria Tsimberidou

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

J J Wheler

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

D S Hong

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

A Naing

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

G S Falchook

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S Moulder

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

B Stephen

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

S Wen

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

R Kurzrock

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

29 February 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Annals of Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1963-1967

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Bevacizumab toxicities and their management in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Combining targeted therapies: practical issues to consider at the bench and bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Ethics of phase 1 oncology studies: reexamining the arguments and data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Responses and toxic deaths in phase I clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

21 June 2018

Equipoise lost: ethics, costs, and the regulation of cancer clinical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

31 October 2018

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

31 October 2018

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

31 October 2018

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092254

31 October 2018

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response in phase I trials of antineoplastic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response and potential pitfalls in phase I clinical trials of anticancer agents conducted in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risks and benefits of phase 1 oncology trials, revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer: the road to Amiens

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22377564

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/ANNONC/MDS027

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22377564%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33399986&oldid=1749477901"